Dominique Heymann

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models

Frederic Blanchard, G. Moriceau, D. Heymann, 2014, PloS one.

Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.

D. Heymann, Benjamin Ory, Dominique Heymann, 2016, Clinical chemistry.

Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells.

Nathalie Caroff, N. Caroff, K. Asehnoune, 2015, Pathogens and disease.

RANK–RANKL signalling in cancer

M. Heymann, D. Heymann, Dominique Heymann, 2016, Bioscience reports.

Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine

M. Heymann, D. Heymann, Dominique Heymann, 2018, Cancers.

Synchrotron hard x-ray microprobe: Fluorescence imaging of single cells

Anatoly Snigirev, Alexandre Simionovici, Christian G. Schroer, 2001 .

First Preclinical Imaging of Primary Cartilage Neoplasm and Its Local Recurrence Using 99mTc-NTP 15-5 Radiotracer

Serge Askienazy, Jean Maublant, J. Maublant, 2009, Journal of Nuclear Medicine.

Synchrotron-induced X-ray microfluorescence on single cells

Anatoly Snigirev, Alexandre Simionovici, Christian G. Schroer, 2001 .

Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANK

Frédéric Blanchard, John T. Gallagher, S. Ricard-Blum, 2006 .

Proteoglycans: key partners in bone cell biology

D. Heymann, Dominique Heymann, François Lamoureux, 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.